Download PDF
Thromb Haemost 2001; 86(06): 1586-1587
DOI: 10.1055/s-0037-1616771
Letters to the Editor
Schattauer GmbH

The Effects of Vitamin K-antagonists on Survival of Patients with Malignancy: A Systematic Analysis

Susanne M. Smorenburg
1   Departments of Vascular Medicine
2   Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
,
Roel Vink
1   Departments of Vascular Medicine
,
Hans-Martin Otten
1   Departments of Vascular Medicine
,
Francis Swaneveld
1   Departments of Vascular Medicine
,
Harry R. Büller
1   Departments of Vascular Medicine
› Author Affiliations
Further Information

Publication History

Received 06 June 2001

Accepted after revision 03 September 2001

Publication Date:
12 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Francis JL, Biggerstaff J, Amirkhosravi A. Hemostasis and malignancy. Semin Thromb Hemost 1998; 24: 93-109.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Smorenburg SM, van Noorden CJF. The complex effects of heparins on cancer progression and metastasis in experimental studies. Pharm Rev 2001; 53: 93-105.
    PubMedGoogle Scholar
  • 3 Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. NEJM 2000; 342: 1953-8.
    CrossrefPubMedGoogle Scholar
  • 4 Collins R, Gray R, Godwin J, Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med 1987; 6: 245-54.
    CrossrefPubMedGoogle Scholar
  • 5 Maurer LH, Herndon JE, Hollis DR, Aisner J, Carey RW, Skarin AT, Perry MC, Eaton WL, Zacharski LL, Hammond S, Green MR. Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study. J Clin Oncol 1997; 15: 3378-87.
    CrossrefPubMedGoogle Scholar
  • 6 Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ, Forcier J, Edwards RL, Headley E, Kim S, O’Donnell JF, O’dell R, Tornyos K, Kwaan HC. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Cancer 1984; 53: 2046-52.
    CrossrefPubMedGoogle Scholar
  • 7 Levine M, Hirsh J, Gent M, Arnold A, Warr D, Falanga A, Samosh M, Bramwell V, Pritchard KI, Stewart D, Goodwin P. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994; 343: 886-9.
    CrossrefPubMedGoogle Scholar
  • 8 Daly L. The first international urokinase/warfarin trial in colorectal cancer. Clin Exp Metastasis 1991; 9: 3-11.
    CrossrefPubMedGoogle Scholar
  • 9 Chahinian AP, Propert KJ, Ware JH, Zimmer B, Perry MC, Hirsh V, Skarin A, Kopel S, Holland JF, Comis RL, Green MR. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol 1989; 7: 993-1002.
    CrossrefPubMedGoogle Scholar
  • 10 Smorenburg SM, Hettiarachchi RJK, Vink R, Buller HR. The effects of unfractionated heparin on survival in patients with malignancy – A systematic review. Thromb Haemost 1999; 82: 1600-4.
    Article in Thieme ConnectPubMedGoogle Scholar